share_log

富士莱(301258.SZ):暂无创新药研发相关业务

Fujilai (301258.SZ): No business related to research and development of innovative drugs at the moment.

Gelonghui Finance ·  Jul 9 03:34

On July 9th, Gelunhui reported that Fujilai (301258.SZ) stated on the investor platform that the company is mainly engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients and health product ingredients. The main products include the thioctic acid series, phosphatidylcholine series, and peptide series. Currently, the company does not have any business related to innovative drugs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment